Literature DB >> 10736066

Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus.

M Jeffrey1, W G Halliday, J Bell, A R Johnston, N K MacLeod, C Ingham, A R Sayers, D A Brown, J R Fraser.   

Abstract

Numbers of neurones, synapses and axon terminals were quantified in a murine scrapie model with severe hippocampal pyramidal cell loss, in which definite clinical scrapie is evident from 226 days post-infection (dpi) and death occurs around 250 dpi. Disease-specific PrP accumulations were first seen at 70 dpi (28% of the incubation period (IP)) in thalamus and as sparse foci within the stratum pyramidale of CA1. By 98 dpi (39% IP), PrP was seen in the stratum radiatum and was found at later stages throughout all levels of the hippocampus. At the ultrastructural level in the stratum radiatum of CA1, a decrease in the numbers of simple synapses from 84 dpi (34% IP) and in perforated synapses from 98 dpi (42% IP) was found using an unbiased stereological method, the disector analysis. Degeneration of axon terminals was found from 98 dpi (39% IP) onwards. Neuronal loss was detected in CA1 from 180 dpi (72% IP). The results suggest that the fundamental lesion in the hippocampus of ME7-infected mice is associated with PrP release from CA1 pyramidal neurones, which perturbs synaptic function and leads to degeneration of preterminal axons, and that subsequent pathological changes including neurone loss are sequelae to this initial insult.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736066     DOI: 10.1046/j.1365-2990.2000.00216.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  92 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

2.  Evidence that Perutz's double-beta-stranded subunit structure for beta-amyloids also applies to their channel-forming structures in membranes.

Authors:  S Jonathan Singer; Nazneen N Dewji
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.

Authors:  Roberto Chiesa; Pedro Piccardo; Emiliano Biasini; Bernardino Ghetti; David A Harris
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

4.  Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models.

Authors:  Charleen T Chu; Edward D Plowey; Ruben K Dagda; Robert W Hickey; Salvatore J Cherra; Robert S B Clark
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

5.  Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease.

Authors:  Michael D Geschwind; Christopher A Potter; Mamta Sattavat; Paul A Garcia; Howard J Rosen; Bruce L Miller; Stephen J DeArmond
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

6.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

7.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Authors:  Zuzana Sisková; Anton Page; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

8.  Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K.

Authors:  Wu-Ling Xie; Qi Shi; Jin Zhang; Bao-Yun Zhang; Han-Shi Gong; Yan Guo; Shao-Bin Wang; Yin Xu; Ke Wang; Cao Chen; Yong Liu; Xiao-Ping Dong
Journal:  J Mol Neurosci       Date:  2013-03-24       Impact factor: 3.444

Review 9.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

10.  Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.

Authors:  Clive Bate; Mourad Tayebi; Luisa Diomede; Mario Salmona; Alun Williams
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.